Sisi Xiao
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells.
Journal: Neoplasia (New York, N.Y.)
Published: December 22, 2022
miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions.
Journal: Cancer medicine
Published: March 26, 2022
Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 07, 2021
Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis.
Journal: Frontiers in cell and developmental biology
Published: September 11, 2020
miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 12, 2020
miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling.
Journal: Cell death & disease
Published: January 17, 2020
Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.
Journal: Molecular carcinogenesis
Published: May 08, 2019
Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.
Journal: Journal of cellular and molecular medicine
Published: April 29, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026